Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
J Prev Alzheimers Dis ; 10(2): 322-327, 2023.
Article in English | MEDLINE | ID: mdl-36946459

ABSTRACT

Early cognitive changes due to Alzheimer's disease (AD) include difficulties in semantic access and working memory. Using a computerized cognitive test developed by our group, called the Memory for Semantically Related Objects test (MESERO), we evaluated if cognitively unimpaired carriers of an autosomal dominant AD (ADAD) mutation performed worse on this test than non-carrier family members. 35 cognitively unimpaired ADAD mutation carriers and 26 non-carrier family members from a Colombian ADAD cohort took the MESERO on a laptop computer. Cognitively unimpaired ADAD carriers had significantly worse MESERO total scores than non-carrier family members, driven by worse performance in semantically-related object sets; group performances did not differ on semantically unrelated object sets. Findings suggest that MESERO performance may be sensitive to subtle cognitive changes associated with AD. Future MESERO research should examine performances between healthy older adults and people at risk for sporadic AD.


Subject(s)
Alzheimer Disease , Humans , Aged , Alzheimer Disease/psychology , Mutation/genetics , Neuropsychological Tests , Colombia
2.
Rev Neurol ; 71(8): 277-284, 2020 Oct 16.
Article in Spanish, English | MEDLINE | ID: mdl-33034365

ABSTRACT

INTRODUCTION: Few studies have examined how manipulating the semantic relationship between objects impacts visual working memory accuracy or reaction time. AIM: To characterize how the semantic relatedness of visual objects impacts working memory accuracy and reaction time in healthy adults using a newly developed mobile-tablet cognitive task. SUBJECTS AND METHODS: A delayed matching to sample paradigm on the tablet task was studied in a sample of 76 community-dwelling adult participants from Spain and Colombia. The tablet task included 80 unique sets of either four or six semantically related or semantically unrelated objects. The accuracy and reaction time of the participants on the task were recorded for analysis. RESULTS: When objects were semantically related, reaction time was greater in the six object sets relative to the four object sets. Age was positively associated with reaction time, but not accuracy across all four task conditions. Participants with fewer years of formal education than the sample median (16 years) exhibited worse response accuracy and slower reaction time on both the four and six semantically related conditions relative to participants with 16 or more years of formal education. CONCLUSIONS: Findings from this study suggest that when objects are semantically related (versus unrelated) and object load is increased, more processing time is needed to determine whether an object was or was not in the encoded set. The results also suggest that greater educational attainment -which likely relates with greater exposure to more technologies- is related with faster and more accurate responses on some task conditions.


TITLE: Memoria de trabajo visual para objetos relacionados semánticamente en adultos sanos.Introducción. Pocos estudios han examinado cómo la manipulación de la relación semántica entre objetos puede influir en el desempeño o el tiempo de reacción en tareas de memoria de trabajo visual. Objetivo. Caracterizar cómo la relación semántica de los objetos afecta el desempeño o el tiempo de reacción en una tarea de memoria de trabajo en adultos sanos utilizando una tarea cognitiva diseñada para el uso con tableta. Sujetos y métodos. Se usó una tarea de emparejamiento demorado (delayed matching to sample) con una muestra de 76 participantes adultos de España y Colombia. La tarea incluyó 80 conjuntos únicos de cuatro o seis objetos relacionados/no relacionados semánticamente. Se registraron las respuestas y el tiempo de reacción de los participantes. Resultados. Cuando los objetos estaban semánticamente relacionados, el tiempo de reacción fue mayor en la condición de seis objetos con respecto a la condición de cuatro objetos. La edad se asoció positivamente con el tiempo de reacción, pero no con la precisión de las respuestas. Los participantes con menos años de educación formal tuvieron un peor de­sempeño y un tiempo de reacción más lento en las condiciones somáticamente relacionadas en relación con los participantes con 16 años o más de educación formal. Conclusión. Los resultados sugieren que, cuando los objetos están semánticamente relacionados y aumenta su número, se necesita más tiempo de procesamiento para determinar si un objeto está o no en el grupo de objetos codificado. Además, un mayor nivel educativo se relaciona con respuestas más rápidas y un mejor desempeño en ciertas condiciones de la tarea.


Subject(s)
Memory, Short-Term , Reaction Time , Semantics , Adult , Cognition , Colombia , Humans , Spain
3.
J Prev Alzheimers Dis ; 6(2): 112-120, 2019.
Article in English | MEDLINE | ID: mdl-30756118

ABSTRACT

The study of individuals with autosomal dominant Alzheimer's disease affords one of the best opportunities to characterize the biological and cognitive changes of Alzheimer's disease that occur over the course of the preclinical and symptomatic stages. Unifying the knowledge gained from the past three decades of research in the world's largest single-mutation autosomal dominant Alzheimer's disease kindred - a family in Antioquia, Colombia with the E280A mutation in the Presenilin1 gene - will provide new directions for Alzheimer's research and a framework for generalizing the findings from this cohort to the more common sporadic form of Alzheimer's disease. As this specific mutation is virtually 100% penetrant for the development of the disease by midlife, we use a previously defined median age of onset for mild cognitive impairment for this cohort to examine the trajectory of the biological and cognitive markers of the disease as a function of the carriers' estimated years to clinical onset. Studies from this cohort suggest that structural and functional brain abnormalities - such as cortical thinning and hyperactivation in memory networks - as well as differences in biofluid and in vivo measurements of Alzheimer's-related pathological proteins distinguish Presenilin1 E280A mutation carriers from non-carriers as early as childhood, or approximately three decades before the median age of onset of clinical symptoms. We conclude our review with discussion on future directions for Alzheimer's disease research, with specific emphasis on ways to design studies that compare the generalizability of research in autosomal dominant Alzheimer's disease to the larger sporadic Alzheimer's disease population.


Subject(s)
Alzheimer Disease/physiopathology , Amyloid beta-Peptides/metabolism , Brain/diagnostic imaging , Peptide Fragments/metabolism , Presenilin-1/genetics , Adolescent , Adult , Alzheimer Disease/diagnostic imaging , Alzheimer Disease/genetics , Alzheimer Disease/metabolism , Amyloid beta-Peptides/blood , Amyloid beta-Peptides/cerebrospinal fluid , Aniline Compounds , Asymptomatic Diseases , Biomarkers/blood , Biomarkers/cerebrospinal fluid , Biomarkers/metabolism , Brain/metabolism , Brain/physiopathology , Child , Colombia , Diffusion Tensor Imaging , Disease Progression , Electroencephalography , Ethylene Glycols , Female , Functional Neuroimaging , Humans , Magnetic Resonance Imaging , Male , Mental Status and Dementia Tests , Middle Aged , Peptide Fragments/blood , Peptide Fragments/cerebrospinal fluid , Positron-Emission Tomography , Radiopharmaceuticals , Tomography, Emission-Computed, Single-Photon , Young Adult
4.
Antimicrob Agents Chemother ; 58(2): 916-22, 2014.
Article in English | MEDLINE | ID: mdl-24277027

ABSTRACT

Since epidemiological cutoff values (ECVs) using CLSI MICs from multiple laboratories are not available for Candida spp. and the echinocandins, we established ECVs for anidulafungin and micafungin on the basis of wild-type (WT) MIC distributions (for organisms in a species-drug combination with no detectable acquired resistance mechanisms) for 8,210 Candida albicans, 3,102 C. glabrata, 3,976 C. parapsilosis, 2,042 C. tropicalis, 617 C. krusei, 258 C. lusitaniae, 234 C. guilliermondii, and 131 C. dubliniensis isolates. CLSI broth microdilution MIC data gathered from 15 different laboratories in Canada, Europe, Mexico, Peru, and the United States were aggregated to statistically define ECVs. ECVs encompassing 97.5% of the statistically modeled population for anidulafungin and micafungin were, respectively, 0.12 and 0.03 µg/ml for C. albicans, 0.12 and 0.03 µg/ml for C. glabrata, 8 and 4 µg/ml for C. parapsilosis, 0.12 and 0.06 µg/ml for C. tropicalis, 0.25 and 0.25 µg/ml for C. krusei, 1 and 0.5 µg/ml for C. lusitaniae, 8 and 2 µg/ml for C. guilliermondii, and 0.12 and 0.12 µg/ml for C. dubliniensis. Previously reported single and multicenter ECVs defined in the present study were quite similar or within 1 2-fold dilution of each other. For a collection of 230 WT isolates (no fks mutations) and 51 isolates with fks mutations, the species-specific ECVs for anidulafungin and micafungin correctly classified 47 (92.2%) and 51 (100%) of the fks mutants, respectively, as non-WT strains. These ECVs may aid in detecting non-WT isolates with reduced susceptibility to anidulafungin and micafungin due to fks mutations.


Subject(s)
Antifungal Agents/pharmacology , Candida/drug effects , Echinocandins/pharmacology , Fungal Proteins/genetics , Lipopeptides/pharmacology , Anidulafungin , Candida/classification , Candida/genetics , Candida/isolation & purification , Candidiasis/epidemiology , Candidiasis/microbiology , Europe/epidemiology , Gene Expression , Humans , Micafungin , Microbial Sensitivity Tests , Mutation , North America/epidemiology , South America/epidemiology
5.
Antimicrob Agents Chemother ; 57(12): 5836-42, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24018263

ABSTRACT

Although Clinical and Laboratory Standards Institute (CLSI) clinical breakpoints (CBPs) are available for interpreting echinocandin MICs for Candida spp., epidemiologic cutoff values (ECVs) based on collective MIC data from multiple laboratories have not been defined. While collating CLSI caspofungin MICs for 145 to 11,550 Candida isolates from 17 laboratories (Brazil, Canada, Europe, Mexico, Peru, and the United States), we observed an extraordinary amount of modal variability (wide ranges) among laboratories as well as truncated and bimodal MIC distributions. The species-specific modes across different laboratories ranged from 0.016 to 0.5 µg/ml for C. albicans and C. tropicalis, 0.031 to 0.5 µg/ml for C. glabrata, and 0.063 to 1 µg/ml for C. krusei. Variability was also similar among MIC distributions for C. dubliniensis and C. lusitaniae. The exceptions were C. parapsilosis and C. guilliermondii MIC distributions, where most modes were within one 2-fold dilution of each other. These findings were consistent with available data from the European Committee on Antimicrobial Susceptibility Testing (EUCAST) (403 to 2,556 MICs) for C. albicans, C. glabrata, C. krusei, and C. tropicalis. Although many factors (caspofungin powder source, stock solution solvent, powder storage time length and temperature, and MIC determination testing parameters) were examined as a potential cause of such unprecedented variability, a single specific cause was not identified. Therefore, it seems highly likely that the use of the CLSI species-specific caspofungin CBPs could lead to reporting an excessive number of wild-type (WT) isolates (e.g., C. glabrata and C. krusei) as either non-WT or resistant isolates. Until this problem is resolved, routine testing or reporting of CLSI caspofungin MICs for Candida is not recommended; micafungin or anidulafungin data could be used instead.


Subject(s)
Antifungal Agents/therapeutic use , Candida/drug effects , Candidiasis/drug therapy , Echinocandins/therapeutic use , Anidulafungin , Candida/growth & development , Candida/isolation & purification , Candidiasis/microbiology , Caspofungin , Drug Resistance, Fungal , Europe , Humans , Lipopeptides/therapeutic use , Micafungin , Microbial Sensitivity Tests/standards , Microbial Sensitivity Tests/statistics & numerical data , North America , Observer Variation , South America , Species Specificity
6.
Antimicrob Agents Chemother ; 56(11): 5898-906, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22948877

ABSTRACT

Epidemiological cutoff values (ECVs) for the Cryptococcus neoformans-Cryptococcus gattii species complex versus fluconazole, itraconazole, posaconazole, and voriconazole are not available. We established ECVs for these species and agents based on wild-type (WT) MIC distributions. A total of 2,985 to 5,733 CLSI MICs for C. neoformans (including isolates of molecular type VNI [MICs for 759 to 1,137 isolates] and VNII, VNIII, and VNIV [MICs for 24 to 57 isolates]) and 705 to 975 MICs for C. gattii (including 42 to 260 for VGI, VGII, VGIII, and VGIV isolates) were gathered in 15 to 24 laboratories (Europe, United States, Argentina, Australia, Brazil, Canada, Cuba, India, Mexico, and South Africa) and were aggregated for analysis. Additionally, 220 to 359 MICs measured using CLSI yeast nitrogen base (YNB) medium instead of CLSI RPMI medium for C. neoformans were evaluated. CLSI RPMI medium ECVs for distributions originating from at least three laboratories, which included ≥95% of the modeled WT population, were as follows: fluconazole, 8 µg/ml (VNI, C. gattii nontyped, VGI, VGIIa, and VGIII), 16 µg/ml (C. neoformans nontyped, VNIII, and VGIV), and 32 µg/ml (VGII); itraconazole, 0.25 µg/ml (VNI), 0.5 µg/ml (C. neoformans and C. gattii nontyped and VGI to VGIII), and 1 µg/ml (VGIV); posaconazole, 0.25 µg/ml (C. neoformans nontyped and VNI) and 0.5 µg/ml (C. gattii nontyped and VGI); and voriconazole, 0.12 µg/ml (VNIV), 0.25 µg/ml (C. neoformans and C. gattii nontyped, VNI, VNIII, VGII, and VGIIa,), and 0.5 µg/ml (VGI). The number of laboratories contributing data for other molecular types was too low to ascertain that the differences were due to factors other than assay variation. In the absence of clinical breakpoints, our ECVs may aid in the detection of isolates with acquired resistance mechanisms and should be listed in the revised CLSI M27-A3 and CLSI M27-S3 documents.


Subject(s)
Antifungal Agents/therapeutic use , Cryptococcosis/drug therapy , Cryptococcosis/epidemiology , Cryptococcus gattii/drug effects , Fluconazole/therapeutic use , Itraconazole/therapeutic use , Pyrimidines/therapeutic use , Triazoles/therapeutic use , Antifungal Agents/pharmacology , Australia/epidemiology , Cryptococcosis/microbiology , Cryptococcus gattii/growth & development , Cryptococcus gattii/isolation & purification , Drug Resistance, Fungal/drug effects , Europe/epidemiology , Fluconazole/pharmacology , Humans , India/epidemiology , Itraconazole/pharmacology , Microbial Sensitivity Tests , North America/epidemiology , Pyrimidines/pharmacology , South Africa/epidemiology , South America/epidemiology , Triazoles/pharmacology , Voriconazole
7.
J Clin Microbiol ; 50(6): 2040-6, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22461672

ABSTRACT

Clinical breakpoints (CBPs) and epidemiological cutoff values (ECVs) have been established for several Candida spp. and the newer triazoles and echinocandins but are not yet available for older antifungal agents, such as amphotericin B, flucytosine, or itraconazole. We determined species-specific ECVs for amphotericin B (AMB), flucytosine (FC) and itraconazole (ITR) for eight Candida spp. (30,221 strains) using isolates from 16 different laboratories in Brazil, Canada, Europe, and the United States, all tested by the CLSI reference microdilution method. The calculated 24- and 48-h ECVs expressed in µg/ml (and the percentages of isolates that had MICs less than or equal to the ECV) for AMB, FC, and ITR, respectively, were 2 (99.8)/2 (99.2), 0.5 (94.2)/1 (91.4), and 0.12 (95.0)/0.12 (92.9) for C. albicans; 2 (99.6)/2 (98.7), 0.5 (98.0)/0.5 (97.5), and 2 (95.2)/4 (93.5) for C. glabrata; 2 (99.7)/2 (97.3), 0.5 (98.7)/0.5 (97.8), and 05. (99.7)/0.5 (98.5) for C. parapsilosis; 2 (99.8)/2 (99.2), 0.5 (93.0)/1 (90.5), and 0.5 (97.8)/0.5 (93.9) for C. tropicalis; 2 (99.3)/4 (100.0), 32 (99.4)/32 (99.3), and 1 (99.0)/2 (100.0) for C. krusei; 2 (100.0)/4 (100.0), 0.5 (95.3)/1 (92.9), and 0.5 (95.8)/0.5 (98.1) for C. lusitaniae; -/2 (100.0), 0.5 (98.8)/0.5 (97.7), and 0.25 (97.6)/0.25 (96.9) for C. dubliniensis; and 2 (100.0)/2 (100.0), 1 (92.7)/-, and 1 (100.0)/2 (100.0) for C. guilliermondii. In the absence of species-specific CBP values, these wild-type (WT) MIC distributions and ECVs will be useful for monitoring the emergence of reduced susceptibility to these well-established antifungal agents.


Subject(s)
Amphotericin B/pharmacology , Antifungal Agents/pharmacology , Candida/drug effects , Candidiasis/microbiology , Flucytosine/pharmacology , Itraconazole/pharmacology , Brazil , Canada , Candida/isolation & purification , Europe , Humans , Microbial Sensitivity Tests/standards , United States
8.
Arch Latinoam Nutr ; 50(3): 249-56, 2000 Sep.
Article in Spanish | MEDLINE | ID: mdl-11347294

ABSTRACT

Disturbances in lipid metabolism during copper deficiency in rats are well recognized. Copper deficiency is associated with the spontaneous retention of hepatic iron. Previous studies have reported that hypercholesterolemia and hypertriglyceridemia are associated with elevated hepatic iron concentrations in copper deficient rats. There was a direct relationship between the magnitude of blood lipids and the concentration of hepatic iron. Based on these data, it has been hypothesized that iron was responsible for the development of lipemia of copper deficiency. In this study was determined the effect of increasing doses of Cu(10, 20 and 50 ppm) in the diet, on the serum total lipids, total cholesterol, triglycerides (triacylglicerols), phospholipids, non-esterified fatty acids (NEFA) and liver iron and zinc concentrations in normal rats. The results were compared with normal rats that received a balanced diet containing 0.6 and 6 ppm of Cu, respectively. The results show that Cu-supplement diminished the cholesterol and triglyceride serum levels, increased the level of phospholipids, NEFA and concomitantly decreased the hepatic concentrations of Fe and Zn. There was a statistically significant (p < 0.05) simple correlation between triglycerides and liver Fe (r = 0.917; R2 = 64.03%), cholesterol and liver Zn (r = 0.872; R2 = 76.07%), cholesterol and liver Fe (r = 0.995; R2 = 99.10%), liver Fe and liver Cu (r = -0.612), liver Fe and liver Zn (r = 0.837), liver Cu and liver Zn (r = -0.612), and serum triglycerides and liver Zn (r = 0.967). The mechanism(s) by which Fe and Zn determine these changes is not known; none of the enzymes that act in cholesterol and triglyceride metabolism and biosynthesis require Fe and/or Zn. The increase of NEFA is due to changes in the process of lipolysis and re-esterification of the fatty acids in blood. However, additional studies are needed for the precise mechanisms of this interrelationships to be clarified.


Subject(s)
Copper/administration & dosage , Dietary Supplements , Iron/analysis , Lipids/blood , Liver/chemistry , Zinc/analysis , Animals , Case-Control Studies , Cholesterol/blood , Copper/deficiency , Male , Phospholipids/blood , Rats , Rats, Wistar , Triglycerides/blood
9.
Diabet Med ; 16(1): 41-8, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10229292

ABSTRACT

AIM: To examine the prevalence of hypertension and the rates of hypertension awareness by investigating treatment and control among respondents to the EURODIAB IDDM Complications Study, and to explore the variation in hypertension management by age, sex and end-organ damage. METHODS: A cross-sectional study, examining 3250 randomly selected Type 1 diabetic patients from 31 diabetes clinics in 16 European countries between 1989 and 1990. Mean age was 32.7 years (SD= 10.0) and mean duration of diabetes mellitus (DM) was 14.7 years (SD=9.3). Subjects were asked about a history of high blood pressure (BP) and current prescribed medications were recorded by the subject's physician. Hypertension was defined as having a systolic BP > or = 140 mmHg or diastolic BP > or = 90 mmHg or current use of antihypertensives. Control was defined as a BP < 130/85 mmHg. RESULTS: Twenty-four per cent of subjects had hypertension, among whom fewer than one-half (48.5%) were aware of a previous diagnosis and a similar proportion (42.2%) were on treatment. Only 11.3% of those with hypertension were both treated and controlled. The majority (81%) of those receiving drug therapy for hypertension were on a single drug, most commonly an angiotensin-converting enzyme inhibitor (47%). CONCLUSION: These data show the extent of undermanagement of hypertension in Type 1 DM across Europe prior to the publication of the St. Vincent Declaration and provide a useful baseline against which future improvements in the management of hypertension can be monitored.


Subject(s)
Diabetes Mellitus, Type 1/complications , Hypertension/epidemiology , Adolescent , Adult , Cross-Sectional Studies , Europe/epidemiology , Female , Humans , Hypertension/drug therapy , Male , Middle Aged , Patient Education as Topic , Prevalence
10.
Arch Latinoam Nutr ; 48(2): 129-33, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9830487

ABSTRACT

The relation of excessive doses of vitamin A with various kidney pathologies is well known however, information concerning the relation of kidney enzyme activity with acute hypervitaminosis A is rather scarce. In this study we describe the kidney enzymatic alterations observed in rats that received daily intramuscular injections of 10,000, 30,000, 50,000 and 100,000 IU of vitamin A palmitate (VA) during seven days (TREATED GROUPS). A comparison is made with the enzyme activity in healthy rats pair-fed and treated with sodium palmitate by intramuscular injection (CONTROL GROUP). The treated rats showed a proportional increase (p < 0.05) in activity of acid maltase, transminases or aminotransferases (GOT and GPT), alkaline phosphatase (ALP) and acid protease with all doses of VA administered. Amylase, lipase and arginase tend to decrease (p < 0.05) in activity only with doses of 50,000 and 100,000 I.U. of VA. Several factors are responsible for these findings, such as kidney necrosis due to release of lysosomal acid hydrolases produced by hypervitaminosis A.


Subject(s)
Alanine Transaminase/metabolism , Aspartate Aminotransferases/metabolism , Hydrolases/metabolism , Hypervitaminosis A/metabolism , Kidney/enzymology , Alkaline Phosphatase/metabolism , Animals , Arginase/metabolism , Glucan 1,4-alpha-Glucosidase/metabolism , Lipase/metabolism , Male , Rats , Rats, Wistar
11.
Arch. latinoam. nutr ; Arch. latinoam. nutr;48(2): 129-33, jun. 1998. tab
Article in English | LILACS | ID: lil-226051

ABSTRACT

The relation of excessive doses of vitamin A with various kidney pathologies is well known however, information concerning the relation of kidney enzyme activity with acute hypervitaminosis A is rather scarce. In this study we describe the kidney enzymatic alterations observed in rats that received daily intramuscular injectiosn of 10.000, 30.000, 50.000 and 100.000IU of vitamin A palmitate (VA) during seven days (TREATED GROUPS). A comparison is made with the enzyme activity in healthy rats pairfed and treated with sodium palmitte by intramuscular injection (CONTROL GROUP). The treated rats showed a proportional increase (<0.05) in activity of acid maltase, transaminases or aminotransferase (GOT and GPT), alkaline phosphatase (ALP) and acid protease with all doses of VA administered, Amylase, lipase and arginase tend to decrease (p<0.05) in activity only with doses of 50.000 and 100.000 I.U. of VA. Several factors are responsible for these findings, such as kidney necrosis due to release of lysosomal acid hydrolases produced by hypervitaminosis A.


Subject(s)
Animals , Male , Rats , Alanine Transaminase/metabolism , Aspartate Aminotransferases/metabolism , Hydrolases/metabolism , Hypervitaminosis A/metabolism , Kidney/enzymology , Alkaline Phosphatase/metabolism , Arginase/metabolism , Glucan 1,4-alpha-Glucosidase/metabolism , Lipase/metabolism , Random Allocation , Rats, Wistar
12.
Rev. Fac. Farm. (Merida) ; 34: 40-8, 1998. tab
Article in Spanish | LILACS | ID: lil-294259

ABSTRACT

En el presente estudio se describe el efecto de dosis elevadas de vitamina K3 (VK: 10 a 50 mg/kg/día) inyectadas intramuscularmente, durante un lapso de 7 días, sobre el contenido sérico y hepático de Ca,Mg,Pi y Cl en ratas blancas macho y se comparan los resultados con lo que sucede en ratas tratadas con dosis iguales de bisulfito de sodio. Los resultados obtenidos demuestran que la vitamina K a dosis elevadas produce una marcada alteración en el contenido sérico y hepático de Ca,Mg y de Pi sin modificar el contenido de Cl. En consecuencia, la hipervitamina K, al igual que lo que sucede con las vitaminas A y D, puede alterar significativamente el metabolismo mineral con graves consecuencias para las diversas actividades enzimáticas corporales


Subject(s)
Animals , Rats , Blood/metabolism , Calcium/administration & dosage , Liver/metabolism , Magnesium/administration & dosage , Vitamin K/administration & dosage , Pharmacy , Venezuela
13.
Arch Latinoam Nutr ; 47(2): 118-22, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9659424

ABSTRACT

Levels of Zn, Cu and Fe were measured in blood serum samples of 320 children: 160 boys and 160 girls randomly selected, ages between 7 and 14 years, all considered healthy and residing in the City of Merida, Venezuela. The metals were determined using flow injection analysis-flame atomic absorption spectrometry. There was a tendency for serum Zn (SZn) to increase with age. There was no significant difference in SZn levels between males and females in the different age groups. Serum copper (SCu) decreases significantly (p < 0.05) with age in male children, whereas it increases in female children. The concentration of serum iron (SFe) tends to be lower than that reported in the literature. However, the age groups studied showed no statistically significant sex and age-related differences. The results are compared with values previously reported for healthy children studied in other communities. The present study has shown that there is a complex interaction between SZn, SCu, SFe and age and sex of the children. On the other hand, our observations also suggest that more detailed studies of these metals should be done, and that the study should include metabolic balances and associations between SZn, SCu, SFe and anthropometric variables (height, weight, body mass index and skinfold thickness).


Subject(s)
Copper/blood , Health , Iron/blood , Zinc/blood , Adolescent , Age Factors , Analysis of Variance , Child , Female , Humans , Male , Sex Factors , Venezuela
14.
J Trace Elem Med Biol ; 10(4): 210-3, 1996 Dec.
Article in English | MEDLINE | ID: mdl-9021671

ABSTRACT

Taking up where a previous paper had left off (10) the purpose of this study was to examine in further detail the serum concentration of manganese of 180 apparently healthy Venezuelan infants (96 boys and 84 girls) ranging from 5 days to 12 months old, all residents of Mérida. The flow injection analysis-atomic absorption spectrophotometric technique was used for the determination of manganese. The mean values of serum manganese were 0.42 +/- 0.12, 0.41 +/- 0.11, 0.39 +/- 0.13, 0.39 +/- 0.1, 0.38 +/- 0.09, 0.37 +/- 0.11, 0.36 +/- 0.12 and 0.29 +/- 0.10 microgram/L in infants 5 days and 1,3,5,7,10,11 and 12 months old, respectively. These values indicate that the average concentration of manganese in serum decreases with age, but the mechanism involved is not yet known, nor are the consequences of the decrease. The statistical analysis did not show any significant influence of sex on the serum value of the metal in the age range of 5 days to 12 months.


Subject(s)
Infant, Newborn/blood , Manganese/blood , Age Factors , Female , Humans , Infant , Male , Sex Factors
15.
BMJ ; 313(7061): 848-52, 1996 Oct 05.
Article in English | MEDLINE | ID: mdl-8870570

ABSTRACT

OBJECTIVE: To examine differences in morbidity and mortality due to non-insulin dependent diabetes in African Caribbeans and Europeans. DESIGN: Cohort study of patients with non-insulin dependent diabetes drawn from diabetes clinics in London. Baseline investigations were performed in 1975-7; follow up continued until 1995. PATIENTS: 150 Europeans and 77 African Caribbeans with non-insulin dependent diabetes. MAIN OUTCOME MEASURES: All cause and cardiovascular mortality; prevalence of microvascular and macrovascular complications. RESULTS: Duration of diabetes was shorter in African Caribbeans, particularly women. African Caribbeans were more likely than the Europeans to have been given a diagnosis after the onset of symptoms and less likely to be taking insulin. Mean cholesterol concentration was lower in African Caribbeans, but blood pressure and body mass index were not different in the two ethnic groups. Prevalence of microvascular and macrovascular complications was insignificantly lower in African Caribbens than in Europeans. 59 Europeans and 16 African Caribbeans had died by the end of follow up. The risk ratio for all cause mortality was 0.41 (95% confidence interval 0.23 to 0.73) (P = 0.002) for African Caribbeans v Europeans. This was attenuated to 0.59 (0.32 to 1.10) (P = 0.1) after adjustment for sex, smoking, proteinuria, and body mass index. Further adjustment for systolic blood pressure, cholesterol concentration, age, duration of diabetes, and treatment made little difference to the risk ratio. Unadjusted risk ratio for cardiovascular and ischaemic heart disease were 0.33 (0.15 to 0.70) (P = 0.004) and 0.37 (0.16 to 0.85) (P = 0.02) respectively. CONCLUSIONS: African Caribbeans with non-insulin dependent diabetes maintain a low risk of heart disease. Management priorities for diabetes developed in one ethnic group may not necessarily be applicable to other groups.


Subject(s)
Diabetes Mellitus, Type 2/ethnology , Diabetes Mellitus, Type 2/mortality , Adult , Africa/ethnology , Age of Onset , Cohort Studies , Diabetes Mellitus, Type 2/complications , Diabetic Angiopathies/ethnology , Diabetic Angiopathies/etiology , Diabetic Angiopathies/mortality , Diabetic Retinopathy/ethnology , Diabetic Retinopathy/etiology , Diabetic Retinopathy/mortality , Europe/ethnology , Female , Humans , London/epidemiology , Male , Middle Aged , Myocardial Ischemia/ethnology , Myocardial Ischemia/etiology , Myocardial Ischemia/mortality , Prevalence , Risk Factors , West Indies/ethnology
16.
J Epidemiol Community Health ; 50(2): 137-9, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8762376

ABSTRACT

STUDY OBJECTIVE: To determine whether ethnic differences in cardiovascular disease mortality persist in people with non-insulin-dependent diabetes mellitus. DESIGN: This was an ecological study in which routine mortality data from 1985-86, which coded all mentioned causes of death, provided the numerator. The UK population derived from 1981 census formed the denominator. SETTING: United Kingdom. PARTICIPANTS: Records of all deaths in people aged 45 years and above were extracted if diabetes was mentioned anywhere on the death certificate. The denominator was aged five years to approximate to the 1986 population. Mortality rates where a cardiovascular underlying cause was given were compared between South Asians, African-Caribbeans, and those born in England and Wales. The latter group formed the standard for directly standardised rate ratios. MAIN RESULTS: Mortality from heart disease was approximately three times higher in diabetic South Asian born men and women than in those with diabetes born in England and Wales. This ethnic difference was greatest in the younger age group. Conversely, stroke mortality rates in African-Caribbeans were 3.5-4 times higher than those in the England and Wales population. Despite this high mortality from stroke, ischaemic heart disease death rates were not high in African-Caribbean men. CONCLUSIONS: Ethnic differences in cardiovascular mortality persisted and were greater in those with diabetes. Thus the high risk of heart disease should be targeted for intervention in South Asians, and the high rates of stroke targeted in African-Caribbeans.


Subject(s)
Cardiovascular Diseases/ethnology , Diabetes Mellitus, Type 2/ethnology , Age Distribution , Aged , Asia, Southeastern/ethnology , Cardiovascular Diseases/mortality , Diabetes Mellitus, Type 2/mortality , Female , Humans , Male , Middle Aged , United Kingdom/epidemiology , West Indies/ethnology
17.
Rev. Fac. Farm. (Merida) ; 32: 2-4, 1996. tab
Article in Spanish | LILACS | ID: lil-259311

ABSTRACT

Sio2, Li,Na,K,Ca,Mg,Cu,Zn,Fe,Pb, and ash content in equisetum bogotense HBK and equisetum giganteum L.(equisetaceae) in aerial parts were determined. These plants are used in natural and homoeopathic medice because of their therapeutic properties


Subject(s)
Silicon Dioxide/analysis , Silicon Dioxide/therapeutic use , Equisetum arvense , Metals/analysis , Metals/classification , Metals/therapeutic use , Plants, Medicinal , Therapeutics , Venezuela
18.
Rev. Fac. Farm. (Merida) ; 32: 26-32, 1996. ilus
Article in Spanish | LILACS | ID: lil-259315

ABSTRACT

En la presente investigación se estudió el efecto protector del selenio (Se) y de la VE (VE) administrados por vía oral sobre la aparición de alteraciones histopatológicas hepáticas en ratas Wistar machos jóvenes sometidas a la ingesta crónica de alcohol. Los animales con ingesta crónica de alcohol sin tratamiento antioxidante mostraron al estudio histológico: marcada esteatosis hepática conjuntamente con congestión, zonas de hemorragia y de necrosis lítica, edema, infiltrados inflamatorios agudos y crónicos, presencia de cuerpos de Mallory en los hepatocitos centrolobulillares y mitocondrias grandes y esféricas. En otros se observó fibrosis periportal y centrolobulillar. El hallazgo más significativo correspondió a las lesiones malignas (carcinoma hepatocelular) encontradas en tres ejemplares de este grupo. En los animales con ingesta crónica de alcohol y tratados simultáneamente con Se + VE, estas alteraciones no se pudieron detectar. En los animales tratados sólo con VE o con Se, los hallazgos histopatológicos fueron más evidentes al comparar con los animales que recibieron los dos nutrientes. Los resultados obtenidos demuestran el efecto crónica del alcohol. Se discute la participación de los radicales libres en la producción de estas alteraciones y se destaca el efecto antioxidante de la VE y sus interacciones bioquímicas con el Se y con la selenoenzima: glutatión peroxidasa (Gpx), un antioxidante preventivo


Subject(s)
Animals , Rats , Alcoholic Beverages , Carcinoma, Hepatocellular/diagnosis , Rats, Wistar/classification , Selenium/therapeutic use , Vitamin E/therapeutic use
19.
Rev Odontol UNESP ; 19(1): 245-50, 1990.
Article in Portuguese | MEDLINE | ID: mdl-2099554

ABSTRACT

The authors looked for the verification of the fatigue of retentive clasps utilized on the removable partial denture. According to this, it was idealized and built on assay machine, that through movements, simulate the insertion and removal of the clasp for a pattern tooth, manufactured on cobalt-chromium which has all the preparation normally utilized to the correct confection of this type of prosthesis. It was utilized three different commercial alloys based on cobalt-chromium: L1-Biosil; L2-Steldent; L3-Duracron. It was utilized the T clasp of Roach, with was tested upon three different proportions among width and thickness: E1-1.7;E2-2.0 and E3-2.3 and was casted through two casting techniques: F1-oxygen-gas and F2-oxygen-acetylene. The clasps were tested on the machine, which allowed the reading of the number of insertion and removal cycles made until fatigue appeared. The obtained results were submitted to the statistic analysis and the authors concluded that: a) L3 (Duracrom) obtained the best results followed by L1 (Biosil) and finally L3 (Steldent); b) among the analyzed thickness, the best results were obtained by E3, followed by E2 and after this E1; c) form the casting techniques, F2 gave us the best results.


Subject(s)
Chromium Alloys , Dental Casting Technique , Denture Retention , Denture, Partial, Removable , Bicuspid , Humans , Materials Testing
20.
Rev Odontol UNESP ; 19(1): 251-8, 1990.
Article in Portuguese | MEDLINE | ID: mdl-2099555

ABSTRACT

The authors tested the T clasp of Roach in three differents proportions among width and thickness: E1-1.7; E2-2.0 and E3-2.3, with a constant length of 15 mm. These clasps were casted with three cobalt-chromium alloys (L1-Biosil; L2-Steldent and L3-Duracrom), through two casting techniques (F1-oxygen-gas and F2-oxygen-acetylene). The fatigue of the clasps were verified by using and assay machine, that through movements, simulate the insertion and removal of the clasps for a pattern which were obtained from a premolar, prepared in a surveyor. This machine detect the fatigue of the clasps and count the number of cycles of insertion and removal realized. The obtained results of the interaction between the analysed factors, were submitted to the statistic analysis and the authors concluded that: a) the interaction of factors, Alloy x Thickness, Alloy x Casting Technique and Thickness x Casting Technique did not change the order of effects that the factors showed separately but gave rise to effects of different magnitude for any observed sense; b) the simultaneous interaction of the factors Alloy x Thickness x Casting Technique confirmed the superiority of the L3 alloy, the thickness E3 and the F2 casting technique.


Subject(s)
Chromium Alloys , Dental Casting Technique , Denture Retention , Bicuspid , Humans , Materials Testing
SELECTION OF CITATIONS
SEARCH DETAIL